Cortistatin: A member of the somatostatin neuropeptide family with distinct physiological functions

Brain Research Reviews

Volumn 33, Issue 2-3, 2000, Pages 228-241

  Spier, Avron D ^a   De Lecea, Luis ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CST; G protein coupled receptor; h current; LTP; Memory; Sleep

Indexed keywords

CORTISTATIN; NEUROPEPTIDE; SOMATOSTATIN; UNCLASSIFIED DRUG;

AMINO ACID COMPOSITION; CHROMOSOMAL LOCALIZATION; CIRCADIAN RHYTHM; GENE EXPRESSION; HUMAN; IN VITRO STUDY; LOCOMOTION; MOUSE; NERVE CONDUCTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN STRUCTURE; RAT; RECEPTOR BINDING; REGULATOR GENE; REVIEW; SEQUENCE HOMOLOGY; SLEEP DEPRIVATION; SLOW WAVE SLEEP;

AMINO ACID SEQUENCE; ANIMALS; CLONING, MOLECULAR; HUMANS; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; SOMATOSTATIN;

EID: 0033818629     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(00)00031-X     Document Type: Review

References (87)

1. F. Abel, K. Ejeskar, R.M. Sjoberg, P. Kogner, T. Martinsson, Fine mapping of a neuroblastoma tumor suppressor candidate gene region in 1p36.2-3 and mutation analysis of the cortistatin gene localized to the region, J. Hum. Genet. 65 (2000) A117 (615).
2. Aird W.C., Parvin J.D., Sharp P.A., Rosenberg R.D. The interaction of GATA-binding proteins and basal transcription factors with GATA box-containing core promoters. A model of tissue-specific gene expression. J. Biol. Chem. 269:1994;883-889.
3. Andrisani O.M., Hayes T.E., Roos B., Dixon J.E. Identification of the promoter sequences involved in the cell specific expression of the rat somatostatin gene. Nucl. Acids Res. 15:1987;5715-5728.
4. Bakhit C., Swerdlow N. Behavioral changes following central injection of cysteamine in rats. Brain Res. 365:1986;159-163.
5. Beranek L., Hajdu I., Gardi J., Taishi P., Obal F.J., Krueger J.M. Central administration of the somatostatin analog octreotide induces captopril-insensitive sleep responses. Am. J. Physiol. 277:1999;1297-1304.
6. Beranek L., Obal F. Jr., Taishi P., Bodosi B., Laczi F., Krueger J.M. Changes in rat sleep after single and repeated injections of the long-acting somatostatin analog octreotide. Am. J. Physiol. 273:1997;R1484-R1491.
7. Braun H., Schulz S., Becker A., Schroder H., Hollt V. Protective effects of cortistatin (CST-14) against kainate-induced neurotoxicity in rat brain. Brain Res. 803:1998;54-60.
8. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., Hunter K., Stanton V.P., Thirion J.P., Hudson T., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member [published erratum appears in Cell 1992 Apr 17;69(2):385]. Cell. 68:1992;799-808.
9. Calbet M., Guadano-Ferraz A., Spier A.D., Maj M., Sutcliffe J.G., Przewlocki R., de Lecea L. Cortistatin and somatostatin mRNAs are differentially regulated in response to kainate. Brain Res. Mol. Brain Res. 72:1999;55-64.
10. Celesia C.G., Jasper H.H. Acetylcholine released from cerebral cortex in relation to state of activation. Neurology. 16:1966;1053-1063.
11. Chambers J., Ames R.S., Bergsma D., Muir A., Fitzgerald L.R., Hervieu G., Dytko G.M., Foley J.J., Martin J., Liu W.S., Park J., Ellis C., Ganguly S., Konchar S., Cluderay J., Leslie R., Wilson S., Sarau H.M. Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature. 400:1999;261-265.
12. Chessell I.P., Black M.D., Feniuk W., Humphrey P.P. Operational characteristics of somatostatin receptors mediating inhibitory actions on rat locus coeruleus neurones. Br. J. Pharmacol. 117:1996;1673-1678.
13. Conlon J.M., Tostivint H., Vaudry H. Somatostatin- and urotensin II-related peptides: molecular diversity and evolutionary perspectives. Regul. Pept. 69:1997;95-103.
14. Connor M., Ingram S.L., Christie M.J. Cortistatin increase of a potassium conductance in rat locus coeruleus in vitro. Br. J. Pharmacol. 122:1997;1567-1572.
15. Criado J.R., Li H., Liapakis G., Spina M., Henriksen S.J., Koob G.F., Reisine T., Sutcliffe J.G., Goodman M., de Lecea L. Structural and compositional determinants of cortistatin activity. J. Neurosci. Res. 56:1999;611-619.
16. Danguir J. Intracerebroventricular infusion of somatostatin selectively increases paradoxical sleep in rats. Brain Res. 367:1986;26-30.
17. Darlison M.G., Richter D. Multiple genes for neuropeptides and their receptors: co-evolution and physiology. Trends Neurosci. 22:1999;81-88.
18. de Lecea L., Criado J.R., Calbet M., Danielson P.E., Henriksen S.J., Sutcliffe J.G., Prospero-Garcia O. Sleep regulates accumulation of the cortical neuropeptide cortistatin. Soc. Neurosci. Abstr. 24:1998;1429.
19. de Lecea L., Criado J.R., Prospero-Garcia O., Gautvik K.M., Schweitzer P., Danielson P.E., Dunlop C.L., Siggins G.R., Henriksen S.J., Sutcliffe J.G. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature. 381:1996;242-245.
20. de Lecea L., del Rio J.A., Criado J.R., Alcantara S., Morales M., Henriksen S.J., Soriano E., Sutcliffe J.G. Cortistatin is expressed in a distinct subset of cortical interneurons. J. Neurosci. 17:1997;5868-5880.
21. de Lecea L., Ruiz-Lozano P., Danielson P., Foye P., Peelle-Kirley J., Frankel W., Sutcliffe J.G. cDNA cloning, mRNA distribution and chromosomal mapping of mouse and human preprocortistatin. Genomics. 42:1997;499-506.
22. Destexhe A., McCormick D.A., Sejnowski T.J. Thalamic and thalamocortical mechanisms underlying 3 Hz spike-and-wave discharges. Prog. Brain Res. 121:1999;289-307.
23. Dunlap J.C. Molecular bases for circadian clocks. Cell. 96:1999;271-290.
24. Flood J.F., Uezu K., Morley J.E. The cortical neuropeptide, cortistatin-14, impairs post-training memory processing. Brain Res. 775:1997;250-252.
25. Fuhrmann G., Heilig R., Kempf J., Ebel A. Nucleotide sequence of the mouse preprosomatostatin gene. Nucl. Acids Res. 18:1990;1287.
26. Fukusumi S., Kitada C., Takekawa S., Kizawa H., Sakamoto J., Miyamoto M., Hinuma S., Kitano K., Fujino M. Identification and characterization of a novel human cortistatin-like peptide. Biochem. Biophys. Res. Commun. 232:1997;157-163.
27. Galanopoulou A.S., Kent G., Rabbani S.N., Seidah N.G., Patel Y.C. Heterologous processing of prosomatostatin in constitutive and regulated secretory pathways. Putative role of the endoproteases furin, PC1, and PC2. J. Biol. Chem. 268:1993;6041-6049.
28. Gardette R., Faivre-Bauman A., Loudes C., Kordon C., Epelbaum J. Modulation by somatostatin of glutamate sensitivity during development of mouse hypothalamic neurons in vitro. Brain Res. Dev. Brain Res. 86:1995;123-133.
29. Goodman R.H., Jacobs J.W., Chin W.W., Lund P.K., Dee P.C., Habener J.F. Nucleotide sequence of a cloned structural gene coding for a precursor of pancreatic somatostatin. Proc. Natl. Acad. Sci. USA. 77:1980;5869-5873.
30. Goodman R.H., Rehfuss R.P., Verhave M., Ventimiglia R., Low M.J. Somatostatin gene regulation: an overview. Metabolism. 39:1990;2-5.
31. + exchange. Nature. 392:1998;626-630.
32. Halliwell J.V., Adams P.R. Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res. 250:1982;71-92.
33. Hashimoto T., Obata K. Induction of somatostatin by kainic acid in pyramidal and granule cells of the rat hippocampus. Neurosci. Res. 12:1991;514-527.
34. Hasselmo M.E., Barkai E. Cholinergic modulation of activity-dependent synaptic plasticity in the piriform cortex and associative memory function in a network biophysical simulation. J. Neurosci. 15:1995;6592-6604.
35. Jasper H.H., Tessier J. Acetylcholine liberation from cerebral cortex during paradoxical (REM) sleep. Science. 172:1971;601-602.
36. R.A. Juarez, M. Rubenstein, E.C. Chan, M.J. Low, Increased growth following normal development in middle-aged somatostatin-deficient mice, Soc. Neurosci. Abstr. 23 (1997) 659.10.
37. Kaltschmidt C., Kaltschmidt B., Baeuerle P.A. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc. Natl. Acad. Sci. USA. 92:1995;9618-9622.
38. Kreienkamp H.J. Molecular biology of the receptors for somatostatin and cortistatin. Results Probl. Cell Differ. 26:1999;215-237.
39. Kreienkamp H.J., Roth A., Richter D. Rat somatostatin receptor subtype 4 can be made sensitive to agonist-induced internalization by mutation of a single threonine (residue 331). DNA Cell Biol. 10:1998;869-878.
40. Kuner R., Kohr G., Grunewald S., Eisenhardt G., Bach A., Kornau H.C. Role of heteromer formation in GABAB receptor function. Science. 283:1999;74-77.
41. Lanneau C., Viollet C., Faivre-Bauman A., Loudes C., Kordon C., Epelbaum J., Gardette R. Somatostatin receptor subtypes sst1 and sst2 elicit opposite effects on the response to glutamate of mouse hypothalamic neurones: an electrophysiological and single cell RT-PCR study. Eur. J. Neurosci. 10:1998;204-212.
42. Lo Conte G., Bartolini L., Casamenti F., Marconcini-Pepeu I., Pepeu G. Lesions of cholinergic forebrain nuclei: changes in avoidance behavior and scopolamine actions. Pharmacol. Biochem. Behav. 17:1982;933-937.
43. Longo V.G. Behavioral and electroencephalographic effects of atropine and related compounds. Pharmacol. Rev. 18:1966;965-996.
44. Luthi A., McCormick D.A. H-current: properties of a neuronal and network pacemaker. Neuron. 21:1998;9-12.
45. Luthi A., McCormick D.A. Ca(2+)-mediated up-regulation of Ih in the thalamus. How cell-intrinsic ionic currents may shape network activity. Ann. NY Acad. Sci. 868:1999;765-769.
46. Marchese A., George S.R., Kolakowski L.F.J., Lynch K.R., O'Dowd B.F. Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology. Trends Physiol. Sci. 20:1999;370-375.
47. Marrosu F., Portas C., Mascia M.S., Casu M.A., Fa M., Giagheddu M., Imperato A., Gessa G.L. Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats. Brain Res. 671:1995;329-332.
48. Maurer R., Gaehwiler B.H., Buescher H.H., Hill R.C., Roemer D. Opiate antagonistic properties of an octapeptide somatostatin analog. Proc. Natl. Acad. Sci. USA. 79:1982;4815-4817.
49. McCormick D.A., Bal T. Sleep and arousal: thalamocortical mechanisms. Ann. Rev. Neurosci. 20:1997;185-215.
50. McCormick D.A., Prince D.A. Acetylcholine induces burst firing in thalamic reticular neurones by activating a potassium conductance. Nature. 319:1986;402-405.
51. McDermott J.C., Cardoso M.C., Yu Y.T., Andres V., Leifer D., Krainc D., Lipton S.A., Nadal-Ginard B. hMef2c gene encodes skeletal muscle- and brain-specific transcription factors. Mol. Cell Biol. 13:1993;2564-2577.
52. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393:1998;333-339.
53. Metherate R., Cox C.L., Ashe J.H. Cellular bases of neocortical activation: modulation of neural oscillations by the nucleus basalis and endogenous acetylcholine. J. Neurosci. 12:1992;4701-4711.
54. Molkentin J.D., Black B.L., Martin J.F., Olson E.N. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell. 83:1995;1125-1136.
55. Molkentin J.D., Li L., Olson E.N. Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity. J. Biol. Chem. 271:1996;17199-17204.
56. Moore S.D., Madamba S.G., Joels M., Siggins G.R. Somatostatin augments the M-current in hippocampal neurons. Science. 239:1988;278-280.
57. Nothacker H.P., Wang Z., McNeill A.M., Saito Y., Merten S., O'Dowd B., Duckles S.P., Civelli O. Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat. Cell Biol. 1:1999;383-385.
58. O'Dowd B., Scheideler M.A., Nguyen T., Cheng R., Rasmussen J.S., Marchese A., Zastawny R., Heng H.H., Tsui L.C., Shi X., et al. The cloning and chromosomal mapping of two novel human opioid-somatostatin-like receptor genes, GPR7 and GPR8, expressed in discrete areas of the brain. Genomics. 28:1995;84-91.
59. Patel Y.C. Somatostatin and its receptor family. Front Neuroendocrinol. 20:1999;157-198.
60. Y.C. Patel, A. Galanopoulou, Processing and intracellular targeting of prosomatostatin-derived peptides: the role of mammalian endoproteases, Ciba Found Symp. 190 (1995) 26-40; discussion 40-50.
61. Pelton J.T., Kazmierski W., Gulya K., Yamamura H.I., Hruby V.J. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors. J. Med. Chem. 29:1986;2370-2375.
62. Pennypacker K.R., Thai L., Hong J.S., McMillian M.K. Prolonged expression of AP-1 transcription factors in the rat hippocampus after systemic kainate treatment. J. Neurosci. 14:1994;3998-4006.
63. Perez J., Vezzani A., Civenni G., Tutka P., Rizzi M., Schupbach E., Hoyer D. Functional effects of D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Trp-NH2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats. Neuroscience. 65:1995;1087-1097.
64. Perez-Otano I., McMillian M.K., Chen J., Bing G., Hong J.S., Pennypacker K.R. Induction of NF-kB-like transcription factors in brain areas susceptible to kainate toxicity. Glia. 16:1996;306-315.
65. Puebla L., Mounchantaf R., Sasi R., Khare S., Bennet H.P.J., James S., Patel Y.C. Processing of rat preprocortistatin in mouse AtT20 cells. J. Neurochem. 73:1999;1273-1277.
66. J.L. Ramirez, R. Sasi, U. Kumar, R. Mouchantaf, V. Otero, M. Rubenstein, M.J. Low, Y.C. Patel, Brain somatostatin receptors (SSTRs) are upregulated in the somatostatin (SST) deficient mouse, Soc. Neurosci. Abstr. 25 (1999) 175.4.
67. Rezek M., Havlicek V., Hughes K.R., Friesen H. Behavioural and motor excitation and inhibition induced by the administration of small and large doses of somatostatin into the amygdala. Neuropharmacology. 16:1977;157-162.
68. Roosterman D., Roth A., Kreienkamp H.J., Richter D., Meyerhof W. Distinct agonist-mediated endocytosis of cloned rat somatostatin receptor subtypes expressed in insulinoma cells. J. Neuroendocrinol. 10:1997;741-751.
69. Roth B.L., Willins D.L. What's all the RAVE about receptor internalization? Neuron. 4:1999;629-631.
70. Schafer M.K., Day R., Cullinan W.E., Chretien M., Seidah N.G., Watson S.J. Gene expression of prohormone and proprotein convertases in the rat CNS: a comparative in situ hybridization analysis. J. Neurosci. 13:1993;1258-1279.
71. Schindler M., Humphrey P.P., Emson P.C. Somatostatin receptors in the central nervous system. Prog. Neurobiol. 50:1996;9-47.
72. Schwartkop C.P., Kreienkamp H.J., Richter D. Agonist-independent internalization and activity of a C-terminally truncated somatostatin receptor subtype 2 (delta349). J. Neurochem. 3:1999;1275-1282.
73. Schweitzer P., Madamba S., Siggins G.R. Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current. Nature. 346:1990;464-467.
74. Shiromani P., Gillin J., Henriksen S. Acetylcholine and the regulation of REM sleep: Basic mechanisms and clinical implications for affective illness and narcolepsy. Ann. Rev. Pharmacol. Toxicol. 27:1987;137-156.
75. 125I]Tyr10-cortistatin-14 labels all five somatostatin receptors. Naunyn Schmiedebergs Arch. Pharmacol. 357:1998;483-489.
76. Sperk G., Wieser R., Widmann R., Singer E.A. Kainic acid induced seizures: changes in somatostatin, substance P and neurotensin. Neuroscience. 17:1986;1117-1126.
77. Steriade M., Contreras D., Curro Dossi R., Nunez A. The slow (<1 Hz) oscillation in reticular thalamic and thalamocortical neurons: scenario of sleep rhythm generation in interacting thalamic and neocortical networks. J. Neurosci. 13:1993;3284-3299.
78. Stewart D.J., MacFabe D.F., Vanderwolf C.H. Cholinergic activation of the electrocorticogram: role of the substantia innominata and effects of atropine and quinuclidinyl benzilate. Brain Res. 322:1984;219-232.
79. Takazawa A., Abraham W.C., Sekino Y. Cysteamine potentiates entorhinal activation of dentate gyrus granule cells in rats. Brain Res. Bull. 33:1994;437-443.
80. Tostivint H., Lihrmann I., Bucharles C., Vieau D., Coulouarn Y., Fournier A., Conlon J.M., Vaudry H. Occurrence of two somatostatin variants in the frog brain: characterization of the cDNAs, distribution of the mRNAs, and receptor-binding affinities of the peptides. Proc. Natl. Acad. Sci. USA. 93:1996;12605-12610.
81. Vasilaki A., Lanneau C., Dornaud P., De Lecea L., Gardette R., Epelbaum J. Cortistatin affects glutamate sensitivity in mouse hypothalamic neurons through activation of sst2 somatostatin receptor subtype. Neuroscience. 88:1999;359-364.
82. Veber D.F., Holly F.W., Nutt R.F., Bergstrand S.J., Brady S.F., Hirschmann R., Glitzer M.S., Saperstein R. Highly active cyclic and bicyclic somatostatin analogues of reduced ring size. Nature. 280:1979;512-514.
83. Vecsei L., Kiraly C., Bollok I., Nagy A., Varga J., Penke B., Telegdy G. Comparative studies with somatostatin and cysteamine in different behavioral tests on rats. Pharmacol. Biochem. Behav. 21:1984;833-837.
84. Vezzani A., Serafini R., Stasi M.A., Vigano G., Rizzi M., Samanin R. A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus. Neuropharmacology. 30:1991;345-352.
85. Weber J.R.M., Skene J.H.P. Identification of a novel repressive element that contributes to neuron-specific gene expression. J. Neurosci. 17:1997;7583-7593.
86. White J.H., Wise A., Main M.J., Green A., Fraser N.J., Disney G.H., Barnes A.A., Emson P., Foord S.M., Marshall F.H. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature. 396:1998;679-682.
87. Winkler J., Suhr S.T., Gage F.H., Thal L.J., Fisher L.J. Essential role of neocortical acetylcholine in spatial memory. Nature. 375:1995;484-487.